Sanofi Files 6-K Reporting Press Release Publication
Ticker: SNYNF · Form: 6-K · Filed: Feb 7, 2025 · CIK: 1121404
| Field | Detail |
|---|---|
| Company | Sanofi (SNYNF) |
| Form Type | 6-K |
| Filed Date | Feb 7, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release
TL;DR
Sanofi dropped a press release in Feb 2025, check Exhibit 99.1 for deets.
AI Summary
In February 2025, Sanofi filed a Form 6-K to report the publication of a press release, attached as Exhibit 99.1. This filing is for the month of February 2025 and is made pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. Sanofi is a foreign private issuer and files annual reports under Form 20-F.
Why It Matters
This filing indicates that Sanofi has released new information to the public, which could contain updates on its business, financial performance, or strategic developments that investors should be aware of.
Risk Assessment
Risk Level: low — This is a routine filing to report the publication of a press release, with no immediate indication of significant new risks or material adverse events.
Key Players & Entities
- Sanofi (company) — Registrant
- February 2025 (date) — Reporting period
- Exhibit 99.1 (document) — Attached press release
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report the publication of a press release by Sanofi in February 2025, as required by Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is attached as Exhibit 99.1?
Exhibit 99.1 is the press release published by Sanofi in February 2025.
What is Sanofi's filing status regarding annual reports?
Sanofi indicates that it files annual reports under Form 20-F.
What is Sanofi's principal executive office address?
Sanofi's principal executive offices are located at 46, avenue de la Grande Armée, 75017 Paris, France.
What is Sanofi's SIC code?
Sanofi's Standard Industrial Classification (SIC) code is 2834, for Pharmaceutical Preparations.
Filing Stats: 181 words · 1 min read · ~1 pages · Grade level 12.7 · Accepted 2025-02-07 11:14:04
Filing Documents
- d840354d6k.htm (6-K) — 8KB
- d840354dex991.htm (EX-99.1) — 13KB
- g840354g0207185041628.jpg (GRAPHIC) — 1KB
- g840354g1223224559421.jpg (GRAPHIC) — 3KB
- 0001193125-25-022452.txt ( ) — 27KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: February 7, 2025 SANOFI By /s/ Alexandra Roger Name: Alexandra Roger Title: Head of Legal Corporate & Finance 3